Viewing StudyNCT00508001



Ignite Creation Date: 2024-05-05 @ 6:35 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00508001
Status: COMPLETED
Last Update Posted: 2016-10-10
First Post: 2007-07-25

Brief Title: Phase II Study of Best Support Care BSC Plus ZD6474Vandetanib in Patients With Inoperable Hepatocellular Carcinoma HCC
Sponsor: Genzyme a Sanofi Company
Organization: Sanofi

Conditions & Keywords Data

Conditions:
Name
Carcinoma Hepatocellular
Keywords:
Name View
Advanced solid malignant tumour View
Hepatocellular carcinoma View